Your browser doesn't support javascript.
loading
Aneuploidy increases resistance to chemotherapeutics by antagonizing cell division.
Replogle, John Michael; Zhou, Wen; Amaro, Adrianna E; McFarland, James M; Villalobos-Ortiz, Mariana; Ryan, Jeremy; Letai, Anthony; Yilmaz, Omer; Sheltzer, Jason; Lippard, Stephen J; Ben-David, Uri; Amon, Angelika.
Afiliação
  • Replogle JM; David H. Koch Institute of Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139; replogle@mit.edu.
  • Zhou W; David H. Koch Institute of Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Amaro AE; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • McFarland JM; David H. Koch Institute of Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Villalobos-Ortiz M; Broad Institute of MIT and Harvard, Cambridge, MA 02139.
  • Ryan J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.
  • Letai A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.
  • Yilmaz O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.
  • Sheltzer J; Department of Medicine, Harvard Medical School, Boston, MA 02115.
  • Lippard SJ; David H. Koch Institute of Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Ben-David U; Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724.
  • Amon A; David H. Koch Institute of Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
Proc Natl Acad Sci U S A ; 117(48): 30566-30576, 2020 12 01.
Article em En | MEDLINE | ID: mdl-33203674

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Divisão Celular / Resistencia a Medicamentos Antineoplásicos / Aneuploidia / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Divisão Celular / Resistencia a Medicamentos Antineoplásicos / Aneuploidia / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article